Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Gabapentin Market, by Application
1.4.2 Asia Pacific Gabapentin Market, by Dosage Form
1.4.3 Asia Pacific Gabapentin Market, by Distribution Channel
1.4.4 Asia Pacific Gabapentin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Gabapentin Market by Application
3.1 Asia Pacific Epilepsy Market by Country
3.2 Asia Pacific Restless Legs Syndrome Market by Country
3.3 Asia Pacific Neuropathic Pain Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Gabapentin Market by Dosage Form
4.1 Asia Pacific Capsule Market by Country
4.2 Asia Pacific Tablet Market by Country
4.3 Asia Pacific Oral Solution Market by Country
Chapter 5. Asia Pacific Gabapentin Market by Distribution Channel
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Retail Pharmacy Market by Country
5.3 Asia Pacific Online Pharmacy Market by Country
Chapter 6. Asia Pacific Gabapentin Market by Country
6.1 China Gabapentin Market
6.1.1 China Gabapentin Market by Application
6.1.2 China Gabapentin Market by Dosage Form
6.1.3 China Gabapentin Market by Distribution Channel
6.2 Japan Gabapentin Market
6.2.1 Japan Gabapentin Market by Application
6.2.2 Japan Gabapentin Market by Dosage Form
6.2.3 Japan Gabapentin Market by Distribution Channel
6.3 India Gabapentin Market
6.3.1 India Gabapentin Market by Application
6.3.2 India Gabapentin Market by Dosage Form
6.3.3 India Gabapentin Market by Distribution Channel
6.4 South Korea Gabapentin Market
6.4.1 South Korea Gabapentin Market by Application
6.4.2 South Korea Gabapentin Market by Dosage Form
6.4.3 South Korea Gabapentin Market by Distribution Channel
6.5 Singapore Gabapentin Market
6.5.1 Singapore Gabapentin Market by Application
6.5.2 Singapore Gabapentin Market by Dosage Form
6.5.3 Singapore Gabapentin Market by Distribution Channel
6.6 Malaysia Gabapentin Market
6.6.1 Malaysia Gabapentin Market by Application
6.6.2 Malaysia Gabapentin Market by Dosage Form
6.6.3 Malaysia Gabapentin Market by Distribution Channel
6.7 Rest of Asia Pacific Gabapentin Market
6.7.1 Rest of Asia Pacific Gabapentin Market by Application
6.7.2 Rest of Asia Pacific Gabapentin Market by Dosage Form
6.7.3 Rest of Asia Pacific Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
Unique Offerings 
